← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 1986First marketed drug
Jul 29, 1974First NDA
Jul 29, 1974Last known activity
Oct 28, 2010
Acquired by Johnson and Johnson on Jan 1, 2001
Timeline
1960s
- Jan 1, 1968
Alza— Founded
1970s
- Jul 29, 1974
pilocarpine— NDA Organization
1990s
- Mar 29, 1996
pseudoephedrine— NDA Secondary Org
- Mar 29, 1996
pseudoephedrine— Marketing Organization
- Mar 17, 1999
Sequus Pharmaceuticals— Acquired
2000s
- Jan 1, 2001
Johnson and Johnson— Acquired By
Drugs by trial phase (24 distinct, 48 trials)
Phase 3 (5 own, 4 via acquisition)
Phase 2 (10 own, 1 via acquisition)
Indications
Approved for
Studied for
- Attention Deficit Disorder with Hyperactivity
- Back Pain
- Cancer Pain
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Chronic Pain
- Colorectal Neoplasms
- Disease
- Enuresis
- Erectile Dysfunction
- Hyperkinesis
- Low Back Pain
- Myelodysplastic Syndromes
- Narcolepsy
- Neoplasms
- Osteoarthritis
- Osteoarthritis, Hip
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Postoperative Pain
- Preleukemia
- Premature Ejaculation
- Prostatitis
- Psoriasis
- Syndrome
- Urinary Bladder, Overactive
- Urinary Incontinence
- Urinary Incontinence, Urge
Marketed drugs (6)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT01230762Study directorPhase 3Oct 28, 2010
- NCT01230762Lead sponsorPhase 3Oct 28, 2010
- NCT00666393Study directorPhase 3Oct 1, 2008
- NCT00666393Lead sponsorPhase 3Oct 1, 2008
- NCT00990418Study directorPhase 1Mar 1, 2008
- NCT00990418Lead sponsorPhase 1Mar 1, 2008
- NCT00566449Study directorPhase 2Dec 1, 2007
- NCT00424931Lead sponsorPhase 2Jan 1, 2007
- NCT00424931Study directorPhase 2Jan 1, 2007
- NCT00411307Study directorPhase 2Dec 12, 2006
- NCT00410540Study directorPhase 3Dec 12, 2006
- NCT00410748Study directorPhase 3Dec 12, 2006
- NCT00410540Lead sponsorPhase 3Dec 12, 2006
- NCT00410878Study directorPhase 1Dec 12, 2006
- NCT00411268Study directorPhase 3Dec 12, 2006
Details
- Founded
- Mountain View, CA, US Jan 1, 1968
- First NDA
- Jul 29, 1974
- Last known activity
- Oct 28, 2010
Designations held
- Priority review